MCID: CPL002
MIFTS: 16

Capillary Lymphangioma

Categories: Cardiovascular diseases, Cancer diseases, Immune diseases

Aliases & Classifications for Capillary Lymphangioma

MalaCards integrated aliases for Capillary Lymphangioma:

Name: Capillary Lymphangioma 12 14 69
Cutaneous Lymphangioma 12
Lymphangioma of Skin 69

Classifications:



External Ids:

Disease Ontology 12 DOID:2286
NCIt 47 C27509
SNOMED-CT 64 445492005
UMLS 69 C1333176

Summaries for Capillary Lymphangioma

MalaCards based summary : Capillary Lymphangioma, also known as cutaneous lymphangioma, is related to microcystic lymphatic malformation and hematopoietic stem cell transplantation. An important gene associated with Capillary Lymphangioma is PROX1 (Prospero Homeobox 1). The drugs Everolimus and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include tongue.

Related Diseases for Capillary Lymphangioma

Diseases related to Capillary Lymphangioma via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 microcystic lymphatic malformation 11.2
2 hematopoietic stem cell transplantation 9.7 LYVE1 PROX1
3 glossitis 9.7
4 lymphangioma 9.7
5 adult pineoblastoma 9.4 HBA1 PROX1
6 hyperlucent lung 9.3 HBA1 PROX1
7 extragonadal germ cell cancer 9.1 HBA1 PROX1
8 lateral sclerosis 9.0 HBA1 LYVE1 PROX1
9 thymus adenocarcinoma 9.0 HBA1 LYVE1 PROX1
10 renal adenoma 8.9 HBA1 LYVE1 PROX1

Graphical network of the top 20 diseases related to Capillary Lymphangioma:



Diseases related to Capillary Lymphangioma

Symptoms & Phenotypes for Capillary Lymphangioma

Drugs & Therapeutics for Capillary Lymphangioma

Drugs for Capillary Lymphangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Everolimus Approved Phase 2 159351-69-6 6442177
2
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
3
Sirolimus Approved, Investigational Phase 2 53123-88-9 5284616 6436030 46835353
4 Anti-Bacterial Agents Phase 2
5 Antibiotics, Antitubercular Phase 2
6 Antifungal Agents Phase 2
7 Anti-Infective Agents Phase 2
8 Immunosuppressive Agents Phase 2

Interventional clinical trials:


id Name Status NCT ID Phase Drugs
1 Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies Active, not recruiting NCT00975819 Phase 2 sirolimus

Search NIH Clinical Center for Capillary Lymphangioma

Genetic Tests for Capillary Lymphangioma

Anatomical Context for Capillary Lymphangioma

MalaCards organs/tissues related to Capillary Lymphangioma:

39
Tongue

Publications for Capillary Lymphangioma

Articles related to Capillary Lymphangioma:

id Title Authors Year
1
Capillary lymphangioma of the tongue complicated by glossitis. ( 13753050 )
1961

Variations for Capillary Lymphangioma

Expression for Capillary Lymphangioma

Search GEO for disease gene expression data for Capillary Lymphangioma.

Pathways for Capillary Lymphangioma

GO Terms for Capillary Lymphangioma

Sources for Capillary Lymphangioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....